Rigaku contract services
ActiveSight, a division of Rigaku Americas Corporation, established itself as the premier partner for structure-based drug design, working with over 30 pharmaceutical and biotechnology companies. Currently, ActiveSight is focusing on the creation of value by applying our expertise to the discovery of novel lead small molecules. In addition, ActiveSight is an active participant in the research community, working with world class institutions and foundations in the pursuit of improving drug discovery methodology and curing human disease.
Rigaku Americas Corporation also provides XRF contract services.
Click here to make this your Rigaku home page.